Nestec S.a.

L'oreal

Societe Des Produits Nestle S.a.

Nicolas Page

Serge Andre Dominique Rezzi

Stephane Duboux

Philippe Alexandre Guy

Bertrand Bourqui

Francis Foata

Francia Jacqueline Arce Vera

Timo Buetler

Rachid Bel-Rhlid

Thomas Raab

Isabelle Castiel

Harald Bruessow

Vanessa Crespy

Marjorie Guitard

Wilbert Sybesma

Sylvain Lengacher

Pierre Julius Magistretti

Biljana Bogicevic

Jeroen Andre Muller

Guenolee Eliane Marie Prioult

Jane Durga

Karin Kraehenbuehl

Evelyne Ruchti

Igor Allaman

Christophe Cavin

Benoit Marsaux

Thomas Sasse

Stéphane Duboux

Thomas Wolfgang Raab

Serge André Dominique Rezzi

Fabrizio Arigoni

The present invention relates to compositions comprising galactooligosaccharides (GOS) and probiotic bacteria obtained by a process comprising the step of growing the bacteria in a medium comprising GOS, such composition having the effect of boosting the synbiotic effect of the probiotic bacteria with the GOS. Health benefits of the probiotic bacteria as obtained by such a fermentation process are also contemplated.

Probiotic bacteria preconditioned in a GOS-containing medium and use thereof

The present invention relates generally to the field of enhancing skin appearance. One aspect of the invention aims to provide a composition comprising 4-oxo-2-pentenoic acid for use in the reduction or prevention of regions of the skin with darker pigmentation. The present invention also relates to cosmetic use of a composition comprising 4-oxo-2-pentenoic acid for the reduction or prevention of regions of the skin with darker pigmentation.

4-oxo-2-pentenoic acid and skin pigmentation

The present invention relates generally to compositions with a health benefit. In particular, the invention relates to treatment or prevention of liver disorders. A subject matter of the invention is a composition comprising 4-oxo-2-pentenoic acid for use in the treatment or prevention of liver disorders. A further subject matter of the invention is a composition comprising 4-oxo-2-pentenoic acid for use in the treatment or prevention of liver disorders linked to an insufficient activity of phase II enzymes in the liver.

4-oxo-2-pentenoic acid and liver disorders

The present invention relates to compositions of rosmarinic acid or its derivatives and to the use of a hydrolytic enzyme or of microorganism containing or producing hydrolytic enzymes in these compositions. The invention also pertains to methods for improving the biological effects of the rosemary extracts and for administering such compositions to a human or animal subject for improving the skin, coat, hair or health of the subject.

Biological effects of compositions of rosmarinic acid

The present invention relates generally to compositions with a health benefit. In particular, the invention relates to the field of brain health, for example brain protection, maintenance of cognitive function, prevention of cognitive decline and prevention of cognitive disorders. A subject matter of the invention is a composition comprising 4-oxo-2-pentenoic acid for use in the treatment or prevention of cognitive decline.

4-oxo-2-pentenoic acid and brain health

The present invention relates generally to compositions with a health benefit. In particular, the invention relates to the field of cardiovascular disorders, for example, atherosclerosis, high blood pressure, coronary heart disease, myocardial infarction, angina pectoris, stroke, and heart failure. A subject matter of the invention is a composition comprising 4-oxo-2-pentenoic acid for use in the treatment or prevention of cardiovascular disorders.

4-oxo-2-pentenoic acid and cardiovascular health

Biological effects of compositions comprising rosmarinic acid

The invention relates to compositions for preparing a beverage, the compositions comprise a microorganism and/or an enzyme capable of hydrolysing chlorogenic acids of a coffee extract to phenolic acids. When a beverage prepared with the compositions of the invention is consumed chlorogenic acids present in coffee extract is hydrolysed to improve antioxidant and/or anti-inflammatory properties compared to a similar conventional beverage.

Compositions for preparing a coffee beverage comprising hydrolysed chlorogenic acid

Growing community of inventors

Lausanne, Switzerland

Nicolas Page